An overview of the CIRM Alpha Stem Cell Clinic at UC San Diego Health
The mission of the Alpha Stem Cell Clinic at UC San Diego Health is to accelerate the development, implementation and administration of safe and effective stem cell-based human therapies.
The Alpha Stem Cell Clinic at UC San Diego Health is one of five alpha clinics in a network designated by the California Institute for Regenerative Medicine (CIRM), the states stem cell agency. It is the cell therapy arm of the Sanford Stem Cell Clinical Center that specializes in early phase, first-in-human trials. Visit the Sanford Stem Cell Clinical Center's website.
The alpha clinics are intended to create the long-term, networked infrastructure needed to launch and conduct numerous, extensive clinical trials of stem cell-related drugs and therapies in humans, including those developed by independent California-based investigators and companies. These trials are requisite before any new drug or treatment can be approved for clinical use.
The clinics will emphasize public education to raise awareness and understanding of stem cell science. This will combat stem cell tourism and the marketing of unproven, unregulated and potentially dangerous therapies. The clinics will also help establish sustainable business models for future, approved stem cell treatments.
To learn more about participating Alpha Clinics, please visit each clinic's dedicated webpage:
Our current clinical trials include:
Breast Cancer
Chronic Heart Failure
Degenerative Disc Disease
Gastrointestinal
Glioblastoma
Myelodysplastic Syndrome
Find other clinical trials at UC San Diego Health
Learn about how clinical trials work
The Alpha Stem Cell Clinic at UC San Diego Health can provide administrative and other relevant support to scientists and physicians at various stages of development and implementation of clinical trials using stem cell-related therapies.
The Division of Regenerative Medicine at UC San Diego School of Medicine is dedicated to delivering superb state-of-the-art clinical care and bringing the advancement of scientific research in regenerative medicine to the forefront of public and scientific spheres both locally and globally.
The UC San Diego Health / Sharp HealthCare Joint Blood and Marrow Program is the largest blood and marrow transplant (BMT) program in San Diego, one of the largest in California, and a national leader in physician expertise and state-of-the-art treatment.
The Sanford Surgical Training Center supports pre-clinical studies and hands-on training of neurosurgical techniques. Experimental models of spinal and peripheral nerve injury are available for testing pre-clinical cell replacement therapies, clinical immunosuppression protocols in allogeneic and syngeneic cell grafting designs, and organ experimentation and cell grafting. Qualified investigators may be trained on the use of FDA-approved spinal and brain injection devices. The Sanford Surgical Training Center is also working to partner with local contract research organizations (CROs) to develop the infrastructure and administrative support needed to conduct good laboratory practice (GLP) studies.
The UC San Diego Division of Regenerative Medicine will hold its Fifth Annual Symposium on March 15, 2019 at Sanford Consortium for Regenerative Medicine.
This symposium brings together stakeholders from academia, industry, government and the public to discuss developments needed to turn stem cell-based therapies into approved products for patients in need. The program highlights stem cell regeneration in different disease areas and developments with industry partners. An interactive panel will discuss the pitfalls and successes of current stem cell clinical trials.
See the agenda and register for the event
Watch talks from the 2019 symposium on YouTube
Current Enrollment Period: Spring 2019 The UC San Diego CIRM Alpha Stem Cell Clinic is committed to educating patients and professionals, including study staff. We are pleased to invite all clinical research professionals, from coordinators to physicians, to enroll in Translating Stem Cells (CLRE-237).
This 20-hour course is offered via CTRI CREST program. The course may also count as an elective in the MAS program, but applicants do not necessarily need to be enrolled in either the CREST or MAS program to take this course!
The enrollment period is currently closed. Please contact CTRI CREST program with questions, and apply here.
See this downloadable flyer for more information.
Contact
Betty Cabrera, MPH, CCRC Clinical Operations Manager, UC San Diego CIRM Alpha Stem Cell Clinic Phone: 858-534-5932 blcabrera@ucsd.edu
For more information about the program, please contact:
Betty Cabrera, MPH ClinicalOperations Manager, CIRM AlphaStem Cell Clinic
To view the Alpha Clinic's full multidisciplinary team, please see Leadership and Staff.
Meet our stem cell experts in this video playlist
We all have stem cells and they are necessary for our survival. For example, skin stem cells renew and repair our skin. Cells in our bone marrow generate the different cell types in our blood. The stem cells in our bodies are adult stem cells - unspecialized cells found in a tissue or organ that can yield all the specialized types of cells of that tissue or organ.
The term adult stem cells can be misleading because babies and children have them as well. Adult stem cells are also referred to as multipotent stem cells. Multipotent means that they can only generate the cell types in the particular organ in which they are found. However, some studies suggest that under certain conditions, adult stem cells may be able to give rise to cell types of other tissues as well. Another source of multipotent stem cells is umbilical cord blood.
Stem cells that have the potential to generate the cell types in any organ or tissue in the body are called pluripotent stem cells. Embryonic stem cells are pluripotent. Embryonic stem cells come from a blastocyst- a small sphere of cells that results from cell division in a fertilized egg. For research purposes, cells are harvested from the inner cell mass of the blastocyst when it is approximately six days old and consists of around 200 cells. Recently, cells with properties similar to embryonic stem cells, referred to as induced pluripotent stem cells or iPS cells, have been engineered from specialized cells such as skin cells.
Given their unique abilities to renew themselves, researchers are exploring different avenues for using stem cells to treat disease, including:
Stem cells offer tremendous potential to advance medicine; however, current applications may be sometimes exaggerated by the media and others who may not fully understand the science or limitations. Treatments based on stem cells are largely new and there is much we still need to learn. Researchers believe it may take many years, possibly decades in some cases, to realize the full potential of stem cells to treat disease.
UC San Diego Health doctors, researchers and ethicists advise that it is unethical to charge patients for treatments that have not been validated. Unfortunately, there are people who have taken advantage of stem cell publicity to charge fees for treatments that have not been adequately tested for safety and effectiveness. Alleged treatments are offered for a variety of conditions. The Sanford Stem Cell Clinical Center believes that companies often inaccurately portray treatments as safe and effective for a broad range of injury and disease. Potential side effects are downplayed and testimonials are presented instead of evidence from research articles in reputable scientific journals.
The International Society for Stem Cell Research (ISSCR) has expressed concerns about disreputable clinics.
Numerous clinics around the world are exploiting patients hopes by purporting to offer new and effective stem cell therapies for seriously ill patients, typically for large sums of money and without credible scientific rationale, transparency, oversight, or patient protections. The ISSCR is deeply concerned about the potential physical, psychological, and financial harm to those who pursue unproven stem cell therapies and the general lack of scientific transparency and professional accountability of those engaged in these activities.
See"Nine Things To Know About Stem Cell Treatments" for more information.
You can search for new clinical trials, and changes in existing trials at the U.S. National Institutes of Health database:
If you see trials that are of interest to you, we recommend that you read about them carefully, and then print the trial descriptions out for discussion with your doctor. Please keep in touch with respected physicians whom you know and trust for all aspects of your health care.
The rest is here:
CIRM Alpha Stem Cell Clinic | UC San Diego Health
